Delighted to see the publication of this paper from @thisinstitute.cam.ac.uk which Sepsis Research FEAT was pleased to support. Very grateful to all of the charity's supporters who provided input to this important work
Sepsis Research FEAT is delighted to be offering a brand new internship opportunity for summer/autumn 2026 To find out more and apply, visit sepsisresearch.org.uk/charity-upda...
Many of the guidelines also fit into the @jameslindalliance.bsky.social/SRF top 10 research priorities and we continue to call for research funders to look to fund studies that address these priorities to enable better evidence-based guidelines in the future.
Worth noting, however, that many of the recommendations are based on low or very low certainty of evidence, indicating an urgent need for research to address those areas of practice.
Sepsis Research FEAT welcomes the updated Surviving Sepsis international guidelines, which are in line with current UK sepsis guidelines. The charity supports continuous infusions of specific antibiotics (endorsed by @ics-updates.bsky.social
the British Infection Association in 2025).
Our thanks to Jennifer for so kindly sharing her story to raise awareness of sepsis www.mirror.co.uk/news/health/...
Very pleased indeed to see this change: a good thing for UK health services research. A further opportunity to leverage the unique national nature of the NHS to improve health for UK citizens whilst contributing to global research efforts to improve health across all domains
Thank you for all your hard work
Sepsis Research FEAT is delighted to have Samia join the team and looks forward to the development of new strategic partnerships in the advancement of sepsis research & awareness.
With a first-class degree in chemistry and doctoral research in earth sciences and oceanography, Samia started her career at @nature.com and later moved into philanthropy and development for nonprofits.
The founder of Sponsor Scientific, established in 2020, Samia has a track record of developing new, high value funding relationships, including strategic corporate partnerships and sponsorships.
In a move that reflects the charity’s growth and ambition under the leadership of CEO Stephen Moore, Sepsis Research FEAT is delighted to announce the appointment of
@Samia_Burridge as its first Corporate Partnerships Director.
We are delighted to report that the our donate page is now working fine again and that donations can be made once more.
We sincerely apologise for the inconvenience that this has caused. Thank you for your patience and for your ongoing generous support for this charity's research & awareness work.
The team here at Sepsis Research FEAT is aware that many of you have tried to make donations to the charity over the last few days, without success.
This was due to a systems issue outside our control and Sepsis Research FEAT has had a team working hard to rectify the problem.
Delighted to see news of this very promising work from the team at @griffith.edu.au
"Priority 1 reflects a need for patients and clinicians, and today’s guidance takes a step toward addressing that gap. We will continue to support research that improves early diagnosis and saves lives.” – Andrew Conway Morris(
@andymoz78
), Medical Director, Sepsis Research FEAT
The updated guidance reflects one of the top priorities identified through the James Lind Alliance process that Sepsis Research FEAT funded. Research priority number 1 asks ‘how diagnosis can become faster, more accurate and reliable?’.
Sepsis Research FEAT welcomes the new NICE guidance on suspected sepsis in people aged 16 or over. The focus on quicker recognition, better assessment and early treatment supports the work the charity fund across the UK.
t.co/4ApJhMUg3f
This offers huge promise for patient outcomes from sepsis in future and the charity congratulates the team and thanks all those who have made this milestone a reality.
Delighted to see the news from the @edinburgh-uni.bsky.social that the pioneering GenOMICC study has now recruited its 40,000th patient.
Sepsis Research FEAT remains a committed partner in GenOMICC. The recruitment of its 40,000th patient sample marks a pivotal moment for the study.
It's the time of year when the Benefact Group generously gives £1000 each to 120 charities. Please visit movementforgood.com to nominate Sepsis Research FEAT and help secure funding for sepsis research and awareness this festive season 🙏🎅
Please sign up and help us to raise more funds for sepsis research this Christmas 💜
#easyfundraising
Did you know that you can fundraise whilst you do your Christmas shopping?
Over 8,000 retailers will donate to Sepsis Research FEAT at no extra cost to you - so you can raise donations when you buy gifts, decorations, your festive food shop or anything else! It really is that easy.
#easyfundraising
Sepsis Research FEAT Appoints First CEO to Drive Growth and Awareness
ethicalmarketingnews.com/sepsis-resea...
@sepsisresearch.bsky.social
Antibiotic resistance is spreading globally.
📝 The latest GLASS report from the World Health Organization reveals a troubling trend: widespread resistance to commonly used antibiotics, threatening the effectiveness of treatments and the safety of care worldwide.
#AMR #AntimicrobialResistance
We are so grateful to Lily for all she has done to help Sepsis Research FEAT raise awareness of sepsis amongst students and are honoured to be working with her ongoing.
To read the article in full visit www.msn.com/en-us/news/o...
Sepsis Research FEAT was really pleased to help arrange this piece from The Telegraph this week, covering a visit to meet Lily and her dad as she undergoes rehab.
